Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
baqin manyan diwan
- Development stage
- Phase 1
- Lead developer
- Jilin University Science and Technology Center
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Baqin Manyan Diwan is a Traditional Chinese Medicine (TCM) dripping pill formulation developed by the Jilin University Science and Technology Center for the treatment of chronic pharyngitis. It is designed to alleviate clinical symptoms such as throat congestion, pain, and dryness. The formulation utilizes the dripping pill technology to improve the dissolution and absorption of its active herbal components, which typically possess anti-inflammatory and antimicrobial properties. It is primarily marketed and used within the Chinese healthcare system for patients suffering from persistent pharyngeal inflammation.
- Brand names
- Baqin Manyan Diwan
- Other names
- Baqin Chronic Pharyngitis Dripping PillsBaqin DiwanBa Qin Man Yan Di Wan
Beyond the preview
Go deeper on baqin manyan diwan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on baqin manyan diwan.